Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting

Background: Extensive research has established obstructive sleep apnea (OSA) as a contributing factor to numerous cardiovascular and cerebrovascular diseases. However, whether OSA affects in-stent restenosis (ISR) after elective drug-eluting stenting is unclear. Therefore, the obj...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenjie Yang, Zhuoshan Huang, Ke Yang, Dinghui Liu, Junpeng Xiao, Zhen Wu, Ling Jiang, Shan Cao, Xujing Xie, Shujie Yu
Format: Article
Language:English
Published: IMR Press 2025-01-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM25814
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586527362777088
author Wenjie Yang
Zhuoshan Huang
Ke Yang
Dinghui Liu
Junpeng Xiao
Zhen Wu
Ling Jiang
Shan Cao
Xujing Xie
Shujie Yu
author_facet Wenjie Yang
Zhuoshan Huang
Ke Yang
Dinghui Liu
Junpeng Xiao
Zhen Wu
Ling Jiang
Shan Cao
Xujing Xie
Shujie Yu
author_sort Wenjie Yang
collection DOAJ
description Background: Extensive research has established obstructive sleep apnea (OSA) as a contributing factor to numerous cardiovascular and cerebrovascular diseases. However, whether OSA affects in-stent restenosis (ISR) after elective drug-eluting stenting is unclear. Therefore, the objective of this study was to examine the impact of OSA on ISR in patients with coronary heart disease (CHD) who underwent successful elective drug-eluting stent (DES) implantation. Methods: This study retrospectively analyzed CHD patients who successfully underwent elective coronary stent implantation and overnight sleep breathing monitoring and were readmitted for coronary angiography due to symptoms of CHD at 12 to 26 months after percutaneous coronary intervention (PCI). OSA was diagnosed when the apnea-hypopnea index (AHI) was ≥5 events/hour. ISR was defined as >50% restenosis of the vessel diameter in which the DES was implanted. To explore the association between OSA and ISR among patients with CHD, multivariate logistic regression models were developed and utilized. Results: This study enrolled 206 individuals who were diagnosed with CHD, with a mean age of 62.01 ± 10.27 years, and males constituted 76.2% of the patient population. After a median follow-up period of 15 months following DES implantation, there was a significant increase in the incidence of ISR among patients with moderate to severe OSA, increasing from 10.9% to 31.3% (p < 0.001). According to the fully adjusted model, the occurrence of ISR was found to be independently associated with the presence of OSA (OR: 3.247, 95% CI: 1.373–7.677, p = 0.007). Conclusions: In individuals who underwent elective drug-eluting stenting, OSA is an independent risk factor for ISR.
format Article
id doaj-art-ab29a6c21dd94c79a2fca497d09b9d7d
institution Kabale University
issn 1530-6550
language English
publishDate 2025-01-01
publisher IMR Press
record_format Article
series Reviews in Cardiovascular Medicine
spelling doaj-art-ab29a6c21dd94c79a2fca497d09b9d7d2025-01-25T10:41:20ZengIMR PressReviews in Cardiovascular Medicine1530-65502025-01-012612581410.31083/RCM25814S1530-6550(24)01631-4Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting StentingWenjie Yang0Zhuoshan Huang1Ke Yang2Dinghui Liu3Junpeng Xiao4Zhen Wu5Ling Jiang6Shan Cao7Xujing Xie8Shujie Yu9Department of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, Guangdong, ChinaDepartment of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, Guangdong, ChinaDepartment of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, Guangdong, ChinaDepartment of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, Guangdong, ChinaDepartment of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, Guangdong, ChinaDepartment of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, Guangdong, ChinaDepartment of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, Guangdong, ChinaDepartment of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, Guangdong, ChinaDepartment of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, Guangdong, ChinaDepartment of Cardiology, The Third Affiliated Hospital of Sun Yat-sen University, 510630 Guangzhou, Guangdong, ChinaBackground: Extensive research has established obstructive sleep apnea (OSA) as a contributing factor to numerous cardiovascular and cerebrovascular diseases. However, whether OSA affects in-stent restenosis (ISR) after elective drug-eluting stenting is unclear. Therefore, the objective of this study was to examine the impact of OSA on ISR in patients with coronary heart disease (CHD) who underwent successful elective drug-eluting stent (DES) implantation. Methods: This study retrospectively analyzed CHD patients who successfully underwent elective coronary stent implantation and overnight sleep breathing monitoring and were readmitted for coronary angiography due to symptoms of CHD at 12 to 26 months after percutaneous coronary intervention (PCI). OSA was diagnosed when the apnea-hypopnea index (AHI) was ≥5 events/hour. ISR was defined as >50% restenosis of the vessel diameter in which the DES was implanted. To explore the association between OSA and ISR among patients with CHD, multivariate logistic regression models were developed and utilized. Results: This study enrolled 206 individuals who were diagnosed with CHD, with a mean age of 62.01 ± 10.27 years, and males constituted 76.2% of the patient population. After a median follow-up period of 15 months following DES implantation, there was a significant increase in the incidence of ISR among patients with moderate to severe OSA, increasing from 10.9% to 31.3% (p < 0.001). According to the fully adjusted model, the occurrence of ISR was found to be independently associated with the presence of OSA (OR: 3.247, 95% CI: 1.373–7.677, p = 0.007). Conclusions: In individuals who underwent elective drug-eluting stenting, OSA is an independent risk factor for ISR.https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM25814in-stent restenosisobstructive sleep apneadrug-eluting stent
spellingShingle Wenjie Yang
Zhuoshan Huang
Ke Yang
Dinghui Liu
Junpeng Xiao
Zhen Wu
Ling Jiang
Shan Cao
Xujing Xie
Shujie Yu
Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
Reviews in Cardiovascular Medicine
in-stent restenosis
obstructive sleep apnea
drug-eluting stent
title Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
title_full Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
title_fullStr Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
title_full_unstemmed Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
title_short Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
title_sort impact of obstructive sleep apnea on in stent restenosis in coronary heart disease patients after elective drug eluting stenting
topic in-stent restenosis
obstructive sleep apnea
drug-eluting stent
url https://www.imrpress.com/journal/RCM/26/1/10.31083/RCM25814
work_keys_str_mv AT wenjieyang impactofobstructivesleepapneaoninstentrestenosisincoronaryheartdiseasepatientsafterelectivedrugelutingstenting
AT zhuoshanhuang impactofobstructivesleepapneaoninstentrestenosisincoronaryheartdiseasepatientsafterelectivedrugelutingstenting
AT keyang impactofobstructivesleepapneaoninstentrestenosisincoronaryheartdiseasepatientsafterelectivedrugelutingstenting
AT dinghuiliu impactofobstructivesleepapneaoninstentrestenosisincoronaryheartdiseasepatientsafterelectivedrugelutingstenting
AT junpengxiao impactofobstructivesleepapneaoninstentrestenosisincoronaryheartdiseasepatientsafterelectivedrugelutingstenting
AT zhenwu impactofobstructivesleepapneaoninstentrestenosisincoronaryheartdiseasepatientsafterelectivedrugelutingstenting
AT lingjiang impactofobstructivesleepapneaoninstentrestenosisincoronaryheartdiseasepatientsafterelectivedrugelutingstenting
AT shancao impactofobstructivesleepapneaoninstentrestenosisincoronaryheartdiseasepatientsafterelectivedrugelutingstenting
AT xujingxie impactofobstructivesleepapneaoninstentrestenosisincoronaryheartdiseasepatientsafterelectivedrugelutingstenting
AT shujieyu impactofobstructivesleepapneaoninstentrestenosisincoronaryheartdiseasepatientsafterelectivedrugelutingstenting